APA (7th ed.) Citation

Wu, J., Zhou, C., Han, Z., Zhang, H., Yan, J., Chen, J., . . . Zhang, J. (2024). Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases. Signal Transduction and Targeted Therapy, 9(1), 1. https://doi.org/10.1038/s41392-024-02051-4

Chicago Style (17th ed.) Citation

Wu, Jun-Wei, et al. "Anlotinib Plus Chemotherapy as a First-line Treatment for Gastrointestinal Cancer Patients with Unresectable Liver Metastases." Signal Transduction and Targeted Therapy 9, no. 1 (2024): 1. https://doi.org/10.1038/s41392-024-02051-4.

MLA (9th ed.) Citation

Wu, Jun-Wei, et al. "Anlotinib Plus Chemotherapy as a First-line Treatment for Gastrointestinal Cancer Patients with Unresectable Liver Metastases." Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, p. 1, https://doi.org/10.1038/s41392-024-02051-4.